WELCOME TO CERN-MEDICIS !
NEWS!
- 04/2026
The Programme for 2026 has restarted with mass separation of external targets or long-lived CERN sources, with an exciting scientific programme ahead combining proof-of-concept and clinical translation of MEDICIS High Molar Activity grade radionuclides.
- 01/2026
Happy new year from the MEDICIS team and support groups !
- 01/2026
PRISMAP has delivered its last radionuclide last December, the programme coordinated by CERN with MEDICIS mass separation had been a large success, as reported now on CERN website .
- 07/2025
A delegation including IAEA DDG Najat Mokhtar visiting the facility while a first test for Ac-226 theranostic alpha emitter metrology was performed onsite by NPL-Dr Sean Collins.
- 04/2025
The facility has restarted after its shutdown, with an exciting programme ahead – We may witness the 1st use of MEDICIS-separated treatment radionuclides in clinical research in hospitals after the positive decision of the CERN Council.
- 12/2024
CERN hosted (in room Curie !) the 13th MEDICIS collaboration board followed by the 7th Anniversary of the first collected radionuclide!
- 09/2024
CERN hosted the 21st Plenary Meeting of the European Observatory on the the Supply of Medical Radionuclides on 25 and 26 of September 2024.
JOB OPPORTUNITIES
We are looking for a CERN staff position as target materials engineer for MEDICIS and for ISOLDE class A laboratory. Applications are Closed.
GRANTS & DONATIONS – CERN & Society Foundation
The CERN KT-Fund
La Fondation pour l’innovation sur le cancer et la biologie
The ADAM company
The FWO
